Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023

BACKGROUND: In a context where the economic burden of HIV is increasing as HIV patients now have a close to normal lifespan, the availability of generic antiretrovirals commonly prescribed in 2017 and the imminence of patent expiration are expected to provide substantial savings in the coming years....

Descripción completa

Detalles Bibliográficos
Autores principales: Demeulemeester, Romain, Savy, Nicolas, Mounié, Michaël, Molinier, Laurent, Delpierre, Cyrille, Dellamonica, Pierre, Allavena, Clotilde, Pugliesse, Pascal, Cuzin, Lise, Saint-Pierre, Philippe, Costa, Nadège
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044646/
https://www.ncbi.nlm.nih.gov/pubmed/35477443
http://dx.doi.org/10.1186/s12913-022-07859-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044646/
https://www.ncbi.nlm.nih.gov/pubmed/35477443
http://dx.doi.org/10.1186/s12913-022-07859-w

Ejemplares similares